Humphrey Rachel
- SEC CIK
- 0001579781
In the past year, 1 open-market sale filing worth $15.9K and no purchases.
Current role at each company
- PYXS Pyxis Oncology, Inc.Directoras of Mar 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $15.9K
- 1 filing
- Net
- −$15.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Humphrey Rachel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 (view filing) | Apr 14-21, 2025 | 345 daysLate | Humphrey RachelDirector | SSale | −15.5K | $1.02 | −$15.9K | −16.0%81.3K after | 3 lots10b5-1 |